We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+17.1%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$72.5B
AUM Growth
+$8.64B
(+14%)
Cap. Flow
-$411M
Cap. Flow
% of AUM
-0.57%
Top 10 Holdings %
Top 10 Hldgs %
21.89%
Holding
3,099
New
114
Increased
2,324
Reduced
599
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$278M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$23.1M |
| 3 |
Morgan Stanley
MS
|
+$22.8M |
| 4 |
AIRC
Apartment Income REIT Corp.
AIRC
|
+$18.5M |
| 5 |
Peloton Interactive
PTON
|
+$17.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$108M |
| 2 |
Microsoft
MSFT
|
+$73.2M |
| 3 |
Amazon
AMZN
|
+$49.5M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$27.8M |
| 5 |
Meta Platforms (Facebook)
META
|
+$22.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.78% |
| 2 | Financials | 13.46% |
| 3 | Healthcare | 13.26% |
| 4 | Consumer Discretionary | 12.31% |
| 5 | Communication Services | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Aquestive Therapeutics
AQST
$494M
| $106K | ﹤0.01% |
19,740
+2,960
| +18% | +$17.7K |
|
2952
Organogenesis Holdings
ORGO
$239M
| $106K | ﹤0.01% |
14,088
+1,760
| +14% | +$8.36K |
|
2953
Cyclerion Therapeutics
CYCN
$16.7M
| $104K | ﹤0.01% |
1,703
+232
| +16% | +$15.8K |
|
2954
Wipro
WIT
$20B
| $103K | ﹤0.01% |
36,530
+6,840
| +23% | +$17.6K |
|
|
LOGC
2955
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
| $100K | ﹤0.01% |
13,165
+1,720
| +15% | +$11.5K |
|
2956
Minerva Neurosciences
NERV
$199M
| $98K | ﹤0.01% |
5,219
+337
| +7% | +$8.49K |
|
|
CFRX
2957
DELISTED
ContraFect Corporation
CFRX
| $95K | ﹤0.01% |
234
+86
| +58% | +$37.2K |
|
|
LJPC
2958
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $95K | ﹤0.01% |
24,411
+1,320
| +6% | +$5.64K |
|
|
MBII
2959
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $94K | ﹤0.01% |
75,042
+5,797
| +8% | +$6.92K |
|
2960
LG Display
LPL
$3.3B
| $93K | ﹤0.01% |
+10,972
| New | +$78.1K |
|
2961
Security National Financial
SNFCA
$251M
| $93K | ﹤0.01% |
+14,868
| New | +$83.7K |
|
|
RESN
2962
DELISTED
Resonant Inc.
RESN
| $93K | ﹤0.01% |
35,106
+3,740
| +12% | +$8.84K |
|
2963
Dyadic International
DYAI
$36.4M
| $87K | ﹤0.01% |
16,097
+1,865
| +13% | +$12.3K |
|
2964
Pixelworks
PXLW
$41.6M
| $87K | ﹤0.01% |
2,561
+305
| +14% | +$9.2K |
|
2965
Rockwell Medical
RMTI
$28.2M
| $87K | ﹤0.01% |
784
+153
| +24% | +$17.1K |
|
|
ORGS
2966
DELISTED
Orgenesis Inc. Common Stock
ORGS
| $87K | ﹤0.01% |
1,934
+348
| +22% | +$16.8K |
|
2967
Barclays
BCS
$94.1B
| $86K | ﹤0.01% |
10,724
-744
| -6% | -$4.98K |
|
|
PFSW
2968
DELISTED
PFSweb, Inc.
PFSW
| $86K | ﹤0.01% |
12,741
+1,766
| +16% | +$12K |
|
|
CEMI
2969
DELISTED
Chembio diagnostics, Inc.
CEMI
| $85K | ﹤0.01% |
17,866
+1,653
| +10% | +$8.54K |
|
2970
Evolus
EOLS
$501M
| $84K | ﹤0.01% |
25,089
+3,418
| +16% | +$12.8K |
|
2971
Eton Pharmaceutcials
ETON
$1.22B
| $84K | ﹤0.01% |
+10,340
| New | +$79.8K |
|
2972
Rimini Street
RMNI
$471M
| $83K | ﹤0.01% |
18,700
+1,680
| +10% | +$6.64K |
|
|
BXG
2973
DELISTED
Bluegreen Vacations Corporation Common Stock
BXG
| $83K | ﹤0.01% |
+10,400
| New | +$62.2K |
|
2974
Genie Energy
GNE
$383M
| $82K | ﹤0.01% |
11,379
+960
| +9% | +$8.11K |
|
|
CKPT
2975
DELISTED
Checkpoint Therapeutics
CKPT
| $81K | ﹤0.01% |
3,061
+500
| +20% | +$12.7K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2020 Portfolio in Review
As of Q4 2020, RhumbLine Advisers held 3,099 positions worth $72.5B, up 14% from $63.8B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers's Q4 2020 filing shows 114 new, 2,324 increased, 599 reduced and 47 closed positions. Its largest new stake was Apartment Income REIT Corp.: 482,605 shares worth $18.5M. The largest sale was Apple, an estimated $108M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2020 buy was Apartment Income REIT Corp.: 482,605 shares worth $18.5M.
- RhumbLine Advisers added most to Tesla in Q4 2020, an estimated $278M increase.
- RhumbLine Advisers's biggest Q4 2020 reduction was Apple, cutting an estimated $108M.
- RhumbLine Advisers fully exited Immunomedics Inc in Q4 2020, selling an estimated $20.4M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $72.5B portfolio in Q4 2020.
- RhumbLine Advisers opened 114 new positions and closed 47 in Q4 2020.
- RhumbLine Advisers's portfolio value rose 14% quarter-over-quarter to $72.5B.
Based on RhumbLine Advisers's 13F filing for Q4 2020, filed 10 Feb 2021.